| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
8,109 |
7,780 |
$1.57M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
5,825 |
5,557 |
$997K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
3,001 |
2,766 |
$804K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,875 |
1,819 |
$341K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,746 |
1,694 |
$320K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
796 |
791 |
$291K |
| 70450 |
Computed tomography, head or brain; without contrast material |
555 |
553 |
$199K |
| 80053 |
Comprehensive metabolic panel |
8,063 |
7,602 |
$181K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
567 |
560 |
$119K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
307 |
304 |
$113K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
1,244 |
1,230 |
$73K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
1,095 |
395 |
$66K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,459 |
1,432 |
$37K |
| 87631 |
|
641 |
639 |
$35K |
| 82803 |
|
728 |
698 |
$24K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
550 |
546 |
$23K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
776 |
774 |
$23K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,169 |
1,123 |
$17K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,659 |
1,646 |
$14K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
15 |
15 |
$14K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
430 |
175 |
$12K |
| 36415 |
Collection of venous blood by venipuncture |
2,251 |
2,112 |
$12K |
| 80061 |
Lipid panel |
1,674 |
1,671 |
$11K |
| 97010 |
|
768 |
276 |
$10K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
50 |
48 |
$10K |
| 81025 |
|
2,728 |
2,634 |
$9K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
228 |
226 |
$9K |
| 82607 |
|
670 |
670 |
$9K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
787 |
783 |
$7K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
6,055 |
5,756 |
$7K |
| 84439 |
|
758 |
752 |
$6K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
239 |
237 |
$5K |
| 82746 |
|
364 |
364 |
$4K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
271 |
265 |
$4K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
176 |
174 |
$4K |
| 71046 |
Radiologic examination, chest; 2 views |
1,117 |
1,103 |
$3K |
| 81001 |
|
605 |
599 |
$2K |
| 80047 |
|
74 |
73 |
$2K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
3,750 |
3,416 |
$2K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
17 |
17 |
$1K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
907 |
903 |
$1K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
491 |
482 |
$1K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
2,120 |
1,903 |
$794.14 |
| 81003 |
|
2,921 |
2,812 |
$654.82 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
129 |
129 |
$623.06 |
| 86803 |
|
166 |
164 |
$579.31 |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,693 |
1,627 |
$547.80 |
| 71045 |
Radiologic examination, chest; single view |
998 |
980 |
$477.84 |
| 90715 |
|
12 |
12 |
$443.80 |
| 82550 |
|
66 |
65 |
$325.35 |
| 85027 |
|
81 |
81 |
$280.84 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
25 |
25 |
$238.49 |
| 84153 |
|
12 |
12 |
$220.81 |
| 73564 |
|
56 |
51 |
$217.20 |
| 82570 |
|
39 |
38 |
$209.67 |
| 73610 |
|
72 |
69 |
$206.06 |
| 84484 |
|
1,335 |
1,282 |
$189.53 |
| 73630 |
|
98 |
93 |
$153.95 |
| 82043 |
|
24 |
24 |
$123.35 |
| 83540 |
|
24 |
24 |
$120.85 |
| 83735 |
|
27 |
26 |
$110.54 |
| 72110 |
|
12 |
12 |
$102.00 |
| 73130 |
|
28 |
24 |
$93.19 |
| 85651 |
|
24 |
24 |
$44.00 |
| 83690 |
|
68 |
67 |
$41.89 |
| 83605 |
|
357 |
342 |
$31.98 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
2,074 |
1,989 |
$17.49 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,425 |
1,336 |
$7.65 |
| Q9963 |
High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml |
111 |
111 |
$6.49 |
| 85014 |
|
58 |
58 |
$2.12 |
| 83721 |
|
25 |
25 |
$0.00 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
99 |
99 |
$0.00 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
12 |
12 |
$0.00 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
101 |
91 |
$0.00 |
| 96376 |
|
141 |
129 |
$0.00 |
| 87070 |
|
173 |
171 |
$0.00 |
| 87430 |
|
26 |
26 |
$0.00 |